Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
17.5M
-
Shares change
-
-7.64K
-
Total reported value, excl. options
-
$5.3M
-
Value change
-
+$4.11K
-
Put/Call ratio
-
0
-
Number of buys
-
16
-
Number of sells
-
-13
-
Price
-
$0.30
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2025
59 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q2 2025.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.5M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (5.4M shares), BML Capital Management, LLC (3.23M shares), VANGUARD GROUP INC (1.54M shares), Simplify Asset Management Inc. (1.49M shares), Propel Bio Management, LLC (1.49M shares), TANG CAPITAL MANAGEMENT LLC (600K shares), BANK OF AMERICA CORP /DE/ (416K shares), ACADIAN ASSET MANAGEMENT LLC (405K shares), BlackRock, Inc. (376K shares), and Pathstone Holdings, LLC (372K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.